Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Abatacept in Polymyositis and Dermatomyositis
NCT01315938Phase 2Completed
- Sponsor
- Karolinska Institutet
- Start
- Jan 2011
- Primary completion
- Nov 2013
- Modality
- Fc-Fusion Proteins
- Countries
- 2
01
Overview
A Phase 2 trial of abatacept in polymyositis (PM), dermatomyositis (DM), sponsored by Karolinska Institutet. Started Jan 2011; status: completed.
02
Drugs
abatacept
03
Conditions
polymyositis (PM)dermatomyositis (DM)
Beyond the preview
Go deeper on NCT01315938.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01315938.